我院2017—2018年门诊麻醉药品使用情况分析

Analysis on Usage of Anaesthetic Drugs in Outpatient Clinic of Our Hospital From 2017 to 2018

目的分析医院门诊麻醉药品使用情况,为临床合理使用提供参考与依据.方法调取天津市第三中心医院2017-2018年门诊麻醉药品的使用情况,包括药品名称、规格、剂型、数量、金额等信息.结果 2017-2018年,门诊麻醉药品使用量及金额逐年增长,DDDs排名相对稳定,排序前3位药品为硫酸吗啡缓释片(30.0 mg)、芬太尼透皮贴(4.2 mg)、硫酸吗啡缓释片(10.0 mg).DDC排名保持不变,前3的药品分别为盐酸羟考酮缓释片(40.0 mg)、盐酸羟考酮缓释片(10.0 mg)、硫酸吗啡缓释片(10.0 mg).B/A值未见明显波动,基本接近于1.结论医院门诊麻醉药品使用基本合理,但仍有改进空间,进一步加强管理,促进麻醉药品合理使用.

Objective To analyze the usage of anaesthetic drugs in outpatient clinics of our hospital, and to provide reference and basis for rational application of anaesthetic drugs in clinic. Methods The information on the use of anaesthetic drugs in outpatient clinics of Tianjin Third Central Hospital from 2017 to 2018, including drug names, specifications, dosage forms, quantities and sales amounts were collected. Results From 2017 to 2018, usage quantity and consumption of anaesthetic drugs used in outpatient clinics increased year by year, and DDDs ranked relatively stable. The top three drugs were morphine sulfate sustained-release tablets (30.0 mg), fentanyl transdermal patches (4.2 mg) and morphine sulfate sustained-release tablets (10.0 mg). DDC ranking remained unchanged. The top three drugs were oxycodone hydrochloride prolonged-release tablets (40.0 mg), oxycodone hydrochloride prolonged-release tablets (10.0 mg) and morphine sulfate sustained-release tablets (10.0 mg). B/A value of all anaesthetic drugs was close to 1, and there was no obvious fluctuation. Conclusion The application of anaesthetic drugs in outpatient clinics in our hospital is basically reasonable, but there is still room for improvement. We need to further strengthen management to promote the rational use of anaesthetic drugs.